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pair reverse-phase chromatography
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A B S T R A C T
The emergence of new sustainable approaches for insect management using RNA interference (RNAi) based insecticides has created the demand for high throughput
analytical techniques to fully characterise and accurately quantify double stranded RNA (dsRNA) prior to downstream RNAi applications. In this study we have
developed a method for the rapid characterisation of single stranded and double stranded RNA using high resolution RNase mapping in conjunction with ion-pair
reverse-phase chromatography utilising a column with supericially porous particles. The high resolution oligoribonucleotide map provides an important ‘ingerprint’
for identity testing and bioprocess monitoring. Reproducible RNA mapping chromatograms were generated from replicate analyses. Moreover, this approach was
used to provide a method to rapidly distinguish diferent RNA sequences of the same size, based on diferences in the resulting chromatograms. Principal components
analysis of the high resolution RNA mapping data enabled us to rapidly compare multiple HPLC chromatograms and distinguish two dsRNA sequences of diferent
size which share 72% sequence homology. We used the high resolution RNase mapping method to rapidly ingerprint biomanufactured dsRNA across a number of
diferent batches. The resulting chromatograms in conjunction with principal components analysis demonstrated high similarity in the dsRNA produced across the
diferent batches highlighting the potential ability of this method to provide information for batch release in a high throughput manner.
1. Introduction
With the emergence of suitable large scale production systems for
the biomanufacturing of double stranded RNA (dsRNA) for RNAi ap-
plications, the development of high throughput methods that facilitate
the rapid characterisation of dsRNA is required. Mass spectrometry
based methods ofer a powerful approach to characterise RNA. RNase
mass mapping methods have been developed and used for the identi-
ication and quantiication of RNA and RNA post transcriptional mod-
iications [1–10]. Typical worklows involve the puriication of the RNA
[11–14], prior to RNase digestion into smaller oligoribonucleotides that
are more amenable for chromatographic separation and intact mass
measurements [15–18]. Additional sequence information from the oli-
goribonucleotides can be obtained using tandem mass spectrometry
(MS/MS) [19,20]. However, the analysis of nucleic acids in particular
RNA, via mass spectrometry has proved more di cult compared to the
routine applications of proteomics to study biological systems. This is
due to the di culty in purifying and enriching biological RNA, the
formation of RNA-metal ion adducts and problems associated with se-
quencing RNAs due to poor fragmentation in tandem mass spectro-
metry experiments. Furthermore, there is traditionally a trade-of be-
tween chromatographic performance and mobile phase conditions
necessary to obtain high sensitivity during electrospray mass spectro-
metry analysis.
Recent approaches have further developed the use of RNase mass
mapping for the characterisation of dsRNA [21]. RNase digestion of the
dsRNA was performed, using both RNase A and a novel method uti-
lising RNase T1 for RNase mass mapping approaches to further char-
acterise the dsRNA using liquid chromatography interfaced with mass
spectrometry. However detailed analysis of RNA using mass spectro-
metry is time consuming, requires signiicant technical expertise and
expensive instrumentation. In addition, limited software exists for the
automated analysis of typical mass spectrometry data from RNase mass
mapping approaches.
In the production of biopharmaceutical proteins peptide mapping
with reversed-phase (RP) chromatography has been used for the ana-
lyses of recombinant protein biopharmaceuticals delivering compre-
hensive characterisation of products [22–26]. In addition, these
methods are also employed for subsequent lot-to-lot identity testing
(‘ingerprinting’) in support of GMP production. When interfaced with
mass spectrometry, the method enables the identiication of proteins
and their variants, characterisation of post-translational modiications
(PTMs), and conirmation of protein sequences. More recently, Ultra
High Performance Liquid Chromatography (UHPLC) has been em-
ployed, demonstrating superior resolution, higher sensitivity, and much
shorter analysis times compared to traditional HPLC approaches. Pep-
tide mapping approaches have been utilised to assess the stability of
biopharmaceuticals in conjunction with the detection of amino acid
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oxidation and deamidation [27]. Furthermore, these approaches pro-
vide information regarding quality control, analysis of batch-to-batch
consistency and the stability of biopharmaceuticals [24,28,29].
In this study we have developed a method for the rapid character-
isation of single stranded and double stranded RNA using high resolu-
tion RNase mapping in conjunction with ion-pair reverse-phase chro-
matography utilising supericially porous particles. This mapping
approach can be applied to RNA in a similar way that peptide mapping
is used in the production of proteins. Principal components analysis was
employed to analyse the repeatability of replicate analysis, detect minor
diferences between diferent RNA and analyse batch-to-batch varia-
bility in the production of ssRNA and dsRNA.
2. Materials and methods
2.1. Chemicals and reagents
Genes were synthesised by GeneArt® Gene Synthesis (Invitrogen Life
Technologies). Ampicillin sodium salt, tetracycline hydrochloride, iso-
propyl β‑D‑1‑thiogalactopyranoside (IPTG) ≥99%, sodium dodecyl
sulphate (SDS) sodium chloride (NaCl), dimethyl sulfoxide (DMSO)
were from Sigma Aldrich.
2.2. Expression and purification of dsRNA using E. coli HT115 (DE3)
The E. coli strain, HT115 (DE3) [30] was obtained from Cold Spring
Harbor Laboratory, NY, USA. Plasmid pDome11 contained an in-house
designed 481 bp sequence lanked on both sides with T7 promoters was
transformed into E. coli HT115 (DE3) cells. The pDome11 transformed
cells were grown in culture and induced with IPTG to express dsRNAs
as previously described [21].
RNA puriication was performed using the RNASwift method as
previously described [31] with minor modiications. In brief, a pellet of
109 E. coli cells was re-suspended in 200 μL of pre-warmed lysis bufer
(50% DMSO, 0.1% SDS, 0.5M NaCl, 70 °C) and incubated at 70 °C for
3min followed by 3minute incubation at 37 °C. 200 μL warm solution
(4% SDS, 0.5M NaCl, 70 °C) was added followed by addition of 100 μL
5M NaCl. This was centrifuged at 20,238g for 4min and supernatant
transferred to a new Eppendorf tube. 100 μL 60% isopropanol was
added and puriied using solid phase extraction (SPE) as essentially
described [31]. It is important to ensure the same extraction and pur-
iication procedure is used for reproducible IP-RP-HPLC chromato-
grams following RNase digestion.
RNA concentrations were determined using a NanoDrop™ 2000c
spectrophotometer (ThermoFisher Scientiic) by absorbance at 260 nm
normalized to a 1.0 cm (10.0mm) path and A260/280 and A260/230 ratios
obtained [32]. Additional analysis of the RNA was performed using ion-
pair reverse phase chromatography.
2.3. Ion-Pair Reverse Phase High Performance Liquid Chromatography (IP-
RP-HPLC)
Samples were analysed by IP-RP-HPLC on a passivated Agilent 1100
series HPLC using a Proswift RP-1S Monolith column (50mm×4.6mm
I.D. ThermoFisher). Chromatograms were generated using UV detection
at a wavelength of 260 nm. The chromatographic analysis was per-
formed using the following conditions: Bufer A 0.1M triethylammo-
nium acetate (TEAA) pH 7.0 (Fluka, UK); Bufer B 0.1M TEAA, pH 7.0
containing 25% acetonitrile (ThermoFisher). RNA was analysed using
the following gradient. Gradient starting at 22% bufer B to 27% in
2min, followed by a linear extension to 62% bufer B over 15min, then
extended to 73% bufer B over 2.5 min at a low rate of 1.0mL/min at
50 °C.
2.4. In vitro transcription (IVT) of dsRNA and ssRNA
For dsRNA synthesis via in vitro transcription, DNA template was
ampliied using PCR from the plasmid pCOIV that contains a 686 bp
sequence lanked on both sides with T7 promoter sequences and opti-
mised synthetic T7 terminator sequences. In addition, a 561 bp DNA
template lanked on both sides by T7 promoters was generated by PCR
from within the 686 bp sequence of the pCOIV plasmid. For in vitro
synthesis of ssRNA, a DNA template was ampliied using PCR from the
plasmid pCsm40 that contains 521 bp sequence with a T7 promoter. To
create a complementary ssRNA, a 521 bp DNA template identical to the
irst template was used with a T7 promoter on the opposite strand. The
following conditions were used: 0.02 U/μL Q5 High-Fidelity DNA
Polymerase, 200 μM dNTPs, 0.5 μM each of forward and reverse primer
and 10 ng DNA template in a inal volume of 50 μL. The following PCR
parameters were used: the initial denaturation was 1 cycle of 30s at
98 °C, 30 cycles of 30 s at 98 °C, 30 s at 68 °C, and 30 s at 72 °C and a
inal extension at 72 °C for 2 mins. dsRNA and ssRNA were then gen-
erated using in vitro transcription in conjunction with HiScribe™ T7
High Yield RNA Synthesis Kit (New England Biolabs): 10mM NTPs, 1×
reaction bufer, 1 μg DNA template and 2 μL HiScribe™ T7 polymerase
in 20 μL RNase-free water. Compositions of the dsRNA and ssRNAs are
shown in the Supplementary Table 1.
2.5. RNase LC-UV mapping
Following puriication, 2.5 μg of dsRNA in RNase-free water was
incubated with 100 ng RNase A at 37 °C for 30min in a volume of 10 μL.
For RNase T1 mapping, 2.5 μg of puriied dsRNA in 50% DMSO was
incubated at 90 °C for 30 s and allowed to cool to room temp. 2000 U
RNase T1 was added and reaction mix incubated for 15min at 37 °C in a
volume of 10 μL. Subsequently, 2.5 μg of digested dsRNA was analysed
using IP-RP-HPLC-UV using an Accucore C18 column (2.6 μm super-
icially porous silica particles 80 Å pore size 150mm×2.1mm ID). LC
bufer A: 80mM 1,1,1,3,3,3‑Hexaluoro‑2‑propanol (HFIP, Sigma-
Aldrich) with 20mM TEAA (Sigma-Aldrich), LC bufer B: LC bufer A
with 50% acetonitrile (v/v) (ThermoFisher). Starting with 6% bufer B,
an isocratic step was performed for 2 mins followed by a linear ex-
tension to 20% B in 23min, then extension to 30% B over 3min. Extend
to 50% B for 1min and subsequently to 6% B in 0.5 min and hold at 6%
B for 3min at a low rate of 300 μLmin−1, using UV detection at a
wavelength of 260 nm. All RNase mapping IP-RP-HPLC analyses were
performed on a U3000 RSLC system (Thermo Scientiic). Data analysis
was performed in Chromeleon Software v7.2 (Thermo Scientiic).
Average Relative Standard Deviation (%RSD) were calculated for both
retention time and peak area using Chromeleon using the individual
RSD for selected peaks (> 5mAU) in the chromatogram.
2.6. Principal components analysis
The Principal Components Analysis was carried out using SIMCA-P
14.0 Software (Sartorius Stedim Data Analytics). The data were ex-
ported from Chromeleon 7.0 (ThermoFisher) as Excel iles. The data
were reduced by binning into 10 datapoints width bins using the pro-
spectr package in the R-language for statistical computing. This left at
least 19 points across the narrowest chromatographic peak but reduced
the size of the dataset to a more manageable size [33].
3. Results and discussion
3.1. High resolution RNA fingerprinting using IP-RP-HPLC
A 521 nt ssRNA was generated using in vitro transcription and sub-
sequently puriied to remove proteins and contaminants from in vitro
transcription reagents. IP-RP-HPLC analysis in conjunction with a
monolithic polystyrene‑divinylbenzene column was used to
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demonstrate the purity of the ssRNA samples used in this study (see
Supplementary Fig. 1A). Subsequently the puriied ssRNA was digested
with RNase A prior to IP-RP-HPLC analysis in conjunction with IP-RP-
HPLC using supericially porous silica particles to generate a high re-
solution ingerprint of the RNA. We have previously demonstrated the
application of supericially porous silica particles for the analysis of
nucleic acids [34]. The puriied ssRNA was digested with RNase A prior
to IP-RP-HPLC analysis (see Fig. 1A). IP-RP-HPLC analysis was per-
formed using 20mM TEAA, 80mM HFIP and oligoribonucleotides
eluted using an acetonitrile gradient. The results demonstrate the re-
producibility of the IP-RP-HPLC method, an overlay of 3 replicate in-
jections of the same sample is shown in Fig. 1B. Average RSD for re-
tention time and peak area for the peaks shown in the chromatogram
were determined as 0.07% and 4.8% respectively. These results de-
monstrate the ability to rapidly generate a reproducible chromato-
graphic proile of the digested ssRNA using high resolution IP-RP-HPLC.
To further validate the method, the analysis was applied to dsRNA.
dsRNA provides a more complex sample, as typically twice as many
oligoribonucleotides are generated compared to ssRNA following RNase
digestion. This therefore presents a more challenging sample for IP-RP-
HPLC analysis. A 686 bp dsRNA was synthesised using in vitro tran-
scription and puriied prior to analysis by IP-RP-HPLC to conirm the
purity of the dsRNA used in this study (see Supplementary Fig. 1C). The
puriied dsRNA was subsequently digested with RNase A, which cleaves
each strand of dsRNA 3′- to C or U bases, and analysed using IP-RP-
HPLC analysis (see Fig. 2A/B). The results show the more complex
mixture of oligoribonucleotides generated from the 686 bp dsRNA in
contrast to the 521 nt ssRNA (see Fig. 1A). These results show that in
addition to providing a rapid ingerprint of the ssRNA, such approaches
can also provide a reproducible ingerprint of more complex dsRNA.
Average RSD for retention time and peak area for the peaks shown in
the chromatogram were determined as 0.1% and 13.6% respectively.
dsRNA not only generates a more complex mixture of oligor-
ibonucleotides upon RNase A digestion, but presents further challenges
for RNase mapping approaches as most RNase are single strand-speciic
nucleases and therefore not active against dsRNA. We have recently
demonstrated that RNase T1 can be used in RNase mass mapping of
dsRNA in conjunction with the chemical denaturant DMSO [21]. A
short thermal denaturation step in the presence of 50% DMSO de-
natures the dsRNA and prevents subsequent re-annealing. Addition of
RNase T1 selectively cleaves the ssRNA on the 3′-side of G residues.
Therefore, to further characterise and ingerprint the dsRNA, RNase T1
mapping was also performed in conjunction with high resolution IP-RP-
HPLC (see Fig. 2C/D). Average RSD for retention time and peak area for
the peaks shown in the chromatogram were determined as 0.09% and
8.5% respectively.
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Fig. 1. RNase mapping of ssRNA in conjunction with IP-RP-HPLC. A) IP-RP-HPLC chromatogram of 521 nt ssRNA 1 digested with RNase A. Replicate injections of the
same sample made on the same day are shown. B) Overlay of the replicate chromatograms from the RNase A digest of the 521 nt ssRNA 1.
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3.2. Rapid detection of different RNA fragments using high resolution
RNase fingerprinting
To further demonstrate the ability of the high resolution inger-
printing method to rapidly detect diferences between RNA samples,
experiments were performed using ssRNAs of the same size but dif-
ferent sequence. The 521 nt ssRNA (1) sequence and its complementary
sequence ssRNA (2) were in vitro transcribed, puriied (see
Supplementary Fig. 1A/B) and digested using RNase A prior to IP-RP-
HPLC. The resulting chromatograms are shown in Fig. 3A. The results
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Fig. 2. High resolution RNase mapping of dsRNA in conjunction with IP-RP-HPLC A) IP-RP-HPLC chromatogram of 686 bp dsRNA digested with RNase A. Replicate
injections of the same sample made on the same day are shown. B) Overlay of the replicate chromatograms from one RNase A digest of the 686 bp dsRNA. C) IP-RP-
HPLC chromatogram of 686 bp dsRNA digested with RNase T1. Replicate injections of the same sample made on the same day shown. D) Overlay of the replicate
chromatograms from one RNase T1 digest of the 686 bp dsRNA.
A.O. Nwokeoji et al. Journal of Chromatography B 1104 (2019) 212–219
215
show clear diferences in the chromatogram in terms of both retention
times and intensity of the oligoribonucleotides generated, enabling us
to rapidly distinguish two diferent ssRNAs (of the same length) based
on the chromatogram or ingerprint obtained.
To further investigate the method to rapidly identify diferent RNAs,
we chose to analyse two dsRNAs, a 561 bp and 686 bp dsRNA which
share 561 bp of identical sequence. Only 125 bp (18%) of the 686 bp
dsRNA is unique in this example. Therefore, only limited numbers of
diferent oligoribonucleotide fragments will be generated either via
RNase A or RNase T1, making discrimination between these two dif-
ferent RNAs challenging. The 686 and 561 bp dsRNA were in vitro
transcribed, puriied (see Supplementary Fig. 1C/D) and digested using
RNase T1 prior to IP-RP-HPLC (see Fig. 3B). The results show as ex-
pected many of the oligoribonucleotides generated from each dsRNA
are identical, which results in peaks with the same retention time and/
or intensity. However, the results also show that a number of peaks
could be identiied based on diferences in either retention time or in-
tensity in the chromatogram (see Fig. 3B marked as asterisks), in con-
trast to analysis of injection replicates of the same dsRNA (see Fig. 2).
3.3. Analysis of lot-to-lot variation in the biomanufacturing of dsRNA using
RNase mapping
The ability to produce large quantities of dsRNA in either bacterial
systems, by in vitro transcription, in cell-free systems or in planta for
RNA interference applications has generated signiicant demand for the
development and application of high throughput analytical tools for
analysis of dsRNA. In particular, the development of a method that
rapidly characterises dsRNA and assesses potential lot-to-lot variation
in the biomanufacturing of dsRNA. The ability to rapidly assess the
biomanufactured dsRNA in a high throughput manner without the re-
quirement for specialist mass spectrometers and complex data analysis
will provide signiicant advantages in a biomanufacturing environment.
Therefore, in an approach to develop a rapid method for the analysis of
biomanufactured dsRNA, 4 separate batches of E. coli engineered to
express dsRNA were grown and the dsRNA extracted and puriied (see
Supplementary Fig. 2). The IP-RP-HPLC analysis of the RNase A/T1
digests of the dsRNA is shown in Fig. 4A/B and show that reproducible
chromatograms were observed for the dsRNA produced across the 4
diferent batches in this case. These results demonstrate that in these
examples limited lot-to-lot variation of the biomanufactured dsRNA
was observed.
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3.4. Analysis of RNA fingerprinting chromatograms using principal
components analysis
Further comparative analysis of the RNAse mapping data was per-
formed using principal components analysis (PCA) to detect patterns of
similarities/diferences between the resulting chromatograms in an
objective manner. PCA is a method of projecting high dimensional data
down to simple two dimensional plots that describe the similarity of
observations based upon their pattern of variables. The components are
projected in order of variance explained so that the irst components
explain the most prominent features of the data and successive com-
ponents less important features until eventually all that is left is random
variation. Within the SIMCA software the point at which no more useful
information is to be extracted is determined by 7 fold validation which
is a re-prediction technique. One seventh of the data is left out and re-
predicted by the model and the diference between the actual data and
the predicted data is expressed as a Q2 value which is the cross vali-
dated equivalent of R2. The point at which this value of predictivity
drops is deemed the optimum number of components. This PCA ap-
proach has previously been applied to analyse complex chromato-
graphic data [35–39].
In this analysis, the data were transformed using Standard Normal
Variate (SNV) transform which removes any overall amplitude varia-
tion caused by sample dilution or injection variation. The data were
also subjected to mean centering and Pareto scaling. The reason for
applying Pareto scaling was to up-weight medium peaks without in-
creasing baseline noise as would be the case if unit variance scaling
were used. Both transformations were applied within the SIMCA soft-
ware. The software extracted ive principal components by cross vali-
dation explaining 89% of the variance but the irst two components
were suicient to describe the overall similarity of the chromatograms.
The higher order components mainly described minor or artifact fea-
tures in the chromatograms. The two component Scores plot explains
52% of the variance in the data. Each chromatogram is represented as a
point in the plot. The closer together the points the more similar are the
chromatograms. Dissimilarity is shown by the distance between the
points. For clarity the PCA has been performed on the whole dataset but
the result split into three plots which only show the relevant compar-
isons, namely injection replicates, batch replicates and diferent size/
sequences of RNA (see Fig. 5).
Principal component analysis of the injection replicates of the
ssRNA and dsRNA RNase digests is shown in Fig. 5A. The results show
the very tight clustering of injection replicates of the RNase A digest of
the 521 nt ssRNA (1–3 shown in green), 686 bp dsRNA (4–6 shown in
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blue) and the RNase T1 digest of the 686 bp dsRNA (7–9 shown in red).
In addition, the PCA analysis also shows the similarity of the four
batches of biomanufactured 481 bp dsRNA generated from E. coli
HT115 cells digested using either RNase A (16–18 shown in purple) or
RNase T1 digestion (20–23 shown in orange) (see Fig. 5B).
Fig. 5C shows the PCA analysis of the respective chromatograms
generated from the RNase digest a 521 nt ssRNA and its complementary
sequence (Fig. 3A) and two dsRNAs, a 561 bp and 686 bp dsRNA which
share 561 bp of identical sequence (Fig. 3B). The PCA analysis de-
monstrates the diference between the two ssRNA of the same size but
diferent sequence. In addition, the PCA analysis also highlights the
diference in the chromatograms obtained from two dsRNA sequences
of diferent size which share 72% sequence homology (see Fig. 5C).
4. Conclusions
In this study we have performed high resolution RNase mapping in
conjunction with ion-pair reverse phase chromatography utilising su-
pericially porous particles for the rapid ingerprinting of single
stranded and double stranded RNA. The ability to generate a ingerprint
based on the IP-RP chromatogram was used to rapidly detect diferent
RNA sequences of the same size, based on diferences in the resulting
chromatograms. To facilitate the ability to identify small changes in the
chromatographic data which cause signiicant variance among the
samples, PCA analysis was performed. Using this approach we were
able to distinguish two dsRNA fragments of diferent size which share
72% sequence identity. Due to the overlapping peaks in these chro-
matograms, small single nucleotide diferences may sometimes be de-
tected. However, it is more likely larger changes in the dsRNA are re-
quired before a material could be identiied as an incorrect sequence.
We used the high resolution RNase ingerprinting method to rapidly
analyse dsRNA biomanufactured in E. coli across a number of diferent
batches. Moreover the PCA analysis revealed tight clustering of the
injection replicates, demonstrating the reproducibility of the chroma-
tography. A cluster of PCA points from a large group of in-speciication
samples could be used to deine the limits of acceptable process var-
iation with any future samples giving analyses outside of this cluster
being deined as outside what was expected for that product. The re-
sults demonstrate the potential ability to rapidly analyse large numbers
of dsRNA, lot-to-lot variability in the production of dsRNA, and detect
variations in dsRNA generated for batch release. All without the re-
quirement for interfacing with mass spectrometry and the associated
technical expertise required for such analysis.
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interpretation of the references to
colour in this igure legend, the
reader is referred to the web version
of this article.)
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Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jchromb.2018.11.027.
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